| Financial Year |
March 31 2023 |
| Monetary Funds |
722,967,577.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
184,118,854.56 |
| Accounts Receivable |
394,589,122.04 |
| Advances to Suppliers |
15,694,016.58 |
| Other Receivables |
80,365,141.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
192,681,299.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,963,400.34 |
| Total Current Assets |
1,651,777,974.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,204,998.28 |
| Investment Properties |
10,290,635.11 |
| Fixed Assetes |
744,110,984.98 |
| Under-construction Projects |
29,564,278.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,176,524.96 |
| R&D expenses |
-- |
| Goodwill |
10,085,353.67 |
| Long-Term Deferred and Prepaid Expenses |
9,750,915.86 |
| Deferred Income Tax Assets |
11,854,384.29 |
| Other Non-Current Assets |
1,341,415.25 |
| Sub-Total of Non-Current Assets |
897,317,479.39 |
| Total Assets |
2,549,095,453.89 |
| Short-Term Loans |
1,171,153,605.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
361,422,921.12 |
| Accounts Payable |
446,023,959.87 |
| Accounts Received In Advance |
39,734,343.41 |
| Employee Compensation Payable |
38,860,689.32 |
| Taxes Payable |
16,352,644.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,844,683.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
140,674,676.96 |
| Other Current Liabilities |
53,380,192.31 |
| Sub-Total of Current Liabilities |
2,339,812,799.22 |
| Long-term Loans |
96,416,666.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
14,948,578.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,000,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
146,484,869.12 |
| Total Liabilities |
2,486,297,668.34 |
| Paid-In Capital(Or Share Stock) |
765,732,360.00 |
| Capital Surplus |
1,264,106,338.98 |
| Surplus Reserve |
37,123,014.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,986,371,919.07 |
| Minority Stockholder's Interest |
-17,792,009.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
80,589,794.88 |
| Owner's Equity（Stockholder's Equity） |
62,797,785.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,549,095,453.89 |
